New debenture raise..to replace current debenture..!Good news, just released new debenture raise to replace current outstanding debenture due. Conversion possible within 1 year at a share price of .05 cents. All good, and with other good news today with their sustainability result of their Sairiyo drug thats entering approved FDA clinical trial shortly, only brings heighten value to shareholders with raising share price...At .02/ share is a screaming buy currently and may definately be a multi-bagger return to investors. Risk/Reward high. Accumulating at this current share price bottom is an opportunity, in my opinion. Good luck to everyone holding and accumulating share...